BB 1101
Showing 26 - 50 of 782
Laparoscopy, Postoperative Nausea and Vomiting Trial in Jakarta Pusat (Dexamethasone injection, Haloperidol Injection)
Completed
- Laparoscopy
- Postoperative Nausea and Vomiting
- Dexamethasone injection
- Haloperidol Injection
-
Jakarta Pusat, DKI Jakarta, IndonesiaCipto Mangunkusumo Central National Hospital
Feb 15, 2022
Post-endodontic Pain Trial in Cairo (Cryotherapy, Diclofenac sodium, Dexamethasone sodium phosphate)
Recruiting
- Post-endodontic Pain
- Cryotherapy
- +2 more
-
Cairo, EgyptAin Shams University
Oct 13, 2023
Glioblastoma, Malignant Glioma Trial in Duarte (Azeliragon, Biospecimen Collection, Computed Tomography)
Not yet recruiting
- Glioblastoma
- Malignant Glioma
- Azeliragon
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
Mar 6, 2023
Prostatic Tumors, Metastatic Castration-Resistant Prostate Cancer Trial (MK-5684, Dexamethasone, Fludrocortisone)
Not yet recruiting
- Prostatic Neoplasms
- Metastatic Castration-Resistant Prostate Cancer
- MK-5684
- +3 more
- (no location specified)
Nov 13, 2023
Advanced Malignant Tumor, Cancer Fatigue, Metastatic Malignant Tumor Trial in Houston (drug, behavioral, other)
Recruiting
- Advanced Malignant Solid Neoplasm
- +4 more
- Dexamethasone
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Nov 3, 2022
Pain, Postoperative, Opioid Use, Recruitment Trial in New York (Bilateral Erector Spinae Plane Block with bupivacaine and
Enrolling by invitation
- Pain, Postoperative
- +2 more
- Bilateral Erector Spinae Plane Block with bupivacaine and dexamethasone
- No bilateral Erector Spinae Plane Block (no bupivacaine and no dexamethasone)
-
New York, New YorkHospital for Special Surgery (HSS)
Sep 19, 2022
Blepharoconjunctivitis Trial (1% Azithromycin and 0.1% Dexamethasone, 1% Azithromycin, 0.1% Dexamethasone)
Withdrawn
- Blepharoconjunctivitis
- 1% Azithromycin and 0.1% Dexamethasone
- +2 more
- (no location specified)
Nov 19, 2021
Multiple Myeloma Trial (Dara-VRd intensification, Dara-R maintenance, AHCT intensification, Dara-R maintenance, AHCT
Not yet recruiting
- Multiple Myeloma
- Dara-VRd intensification, Dara-R maintenance
- +4 more
- (no location specified)
Dec 13, 2022
Blepharoconjunctivitis Trial (1% Azithromycin and 0.1% Dexamethasone, 1% Azithromycin, 0.1% Dexamethasone)
Completed
- Blepharoconjunctivitis
- 1% Azithromycin and 0.1% Dexamethasone
- +2 more
- (no location specified)
Nov 18, 2021
Multiple Myeloma Trial in Worldwide (ACY-1215 (Ricolinostat) in combination with pomalidomide and dexamethasone)
Active, not recruiting
- Multiple Myeloma
- ACY-1215 (Ricolinostat) in combination with pomalidomide and dexamethasone
-
Atlanta, Georgia
- +25 more
Aug 31, 2022
Postoperative Nausea and Vomiting, Laparoscopic Cholecystectomy Trial in Tanta (Ondansetron 4mg + dexmedetomidine 0.5 ug/kg +
Recruiting
- Postoperative Nausea and Vomiting
- Laparoscopic Cholecystectomy
- Ondansetron 4mg + dexmedetomidine 0.5 ug/kg + normal saline .
- Ondansetron 4mg + dexamethasone 8mg + normal saline.
-
Tanta, Algharbia, EgyptTanta University hospitals
Aug 26, 2023
Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Seattle (Carfilzomib, Dexamethasone, Isatuximab)
Recruiting
- Recurrent Plasma Cell Myeloma
- Refractory Plasma Cell Myeloma
- Carfilzomib
- +3 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Aug 16, 2022
Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Los Angeles (drug, other, biological)
Active, not recruiting
- Recurrent Plasma Cell Myeloma
- Refractory Plasma Cell Myeloma
- Bortezomib
- +4 more
-
Los Angeles, CaliforniaUSC / Norris Comprehensive Cancer Center
Aug 5, 2022
Recurrent Acute Lymphoblastic Leukemia, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Burkitt Leukemia Trial in Houston
Recruiting
- Recurrent Acute Lymphoblastic Leukemia
- +10 more
- Bortezomib
- +8 more
-
Houston, TexasM D Anderson Cancer Center
Sep 21, 2022
Corneal Edema Trial in Giza (Control group, Dexamethasone group, Triamcinolone (TA) group)
Completed
- Corneal Edema
- Control group
- +2 more
-
Giza, Cairo, EgyptKhaled G Abueleinen
Feb 27, 2022
Plasma Cell Myeloma Trial in Atlanta (Belantamab Mafodotin, Dexamethasone, Pomalidomide)
Recruiting
- Plasma Cell Myeloma
- Belantamab Mafodotin
- +2 more
-
Atlanta, GeorgiaEmory University/Winship Cancer Institute
Jul 21, 2022
Anesthesia, Local Trial in Køge, Slagelse (Dexamethasone 12 mg, Placebo, Dexamethasone 24 mg)
Recruiting
- Anesthesia, Local
- Dexamethasone 12 mg
- +2 more
-
Køge, Zealand Region Of Denmark, Denmark
- +1 more
Jan 24, 2023
Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Buffalo, East Hills, West Islip (biological, drug, other)
Active, not recruiting
- Recurrent Plasma Cell Myeloma
- Refractory Plasma Cell Myeloma
- Abatacept
- +3 more
-
Buffalo, New York
- +2 more
Dec 22, 2022
Acute Bilineal Leukemia, Acute Biphenotypic Leukemia, Acute Leukemia of Ambiguous Lineage Trial in Houston (Clofarabine,
Recruiting
- Acute Bilineal Leukemia
- +7 more
- Clofarabine
- +8 more
-
Houston, TexasM D Anderson Cancer Center
Aug 18, 2022
Glioblastoma Multiforme of Brain Trial in Duarte (CHM-1101 CAR-T cells)
Not yet recruiting
- Glioblastoma Multiforme of Brain
- CHM-1101 CAR-T cells
-
Duarte, CaliforniaCity of Hope Medical Center
Dec 19, 2022
Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer American Joint Committee
Recruiting
- Castration-Resistant Prostate Carcinoma
- +2 more
-
Sacramento, CaliforniaUniversity of California Davis Comprehensive Cancer Center
Aug 1, 2022
Postoperative Nausea and Vomiting Trial in Riyadh (Placebo, Ondansetron, Dexamethasone, Midazolam, dexamethasone)
Completed
- Postoperative Nausea and Vomiting
- Placebo
- +2 more
-
Riyadh, Saudi Arabiaking Khaled Eye Specialist hospital
Oct 10, 2021
Toxoplasmosis, Cerebral Trial in Bandung (Dexamethasone, Placebo)
Recruiting
- Toxoplasmosis, Cerebral
- Dexamethasone
- Placebo
-
Bandung, Jawa Barat, IndonesiaHasan Sadikin General Hospital
Nov 14, 2022
Chronic Postoperative Pain Trial in Xi'an (Dexamethasone Palmitate, Dexamethasone Sodium Phosphate)
Not yet recruiting
- Chronic Postoperative Pain
- Dexamethasone Palmitate
- Dexamethasone Sodium Phosphate
-
Xi'an, ChinaXijing Hospital
Jun 28, 2023